Your institution may have access to this item. Find your institution then sign in to continue.

Title: Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer.
Authors: Goldman, Jonathan W.; Rosen, Lee S.; Tolcher, Anthony W.; Papadopoulos, Kyriakos; Beeram, Muralidhar; Shi, Peipei; Pitou, Celine; Bell, Robert; Kulanthaivel, Palaniappan; Zhang, Xuekui; Fink, Aaron; Chan, Edward M.; Shahir, Ashwin; Farrington, Daphne; Patnaik, Amita
Publication: Investigational New Drugs, 2018, Vol 36, Issue 4, p629
ISSN: 0167-6997
Publication type: Academic Journal
DOI: 10.1007/s10637-017-0532-2

We found a match

Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer.